Targeting metabotropic glutamate receptors for the treatment of Parkinson's disease

被引：2
|
作者：
Huot, Philippe [1 ,2 ,3 ]
机构：
[1] Montreal Neurol Inst Hosp Neuro, Neurodegenerat Dis Grp, Montreal, PQ H3A 2B4, Canada
[2] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada
[3] McGill Univ, Dept Neurosci, Div Neurol, Movement Disorder Clin,Hlth Ctr, Montreal, PQ H3A 2B4, Canada
来源：
NEURODEGENERATIVE DISEASE MANAGEMENT | 2023年 / 13卷 / 04期
基金：
加拿大自然科学与工程研究理事会;
关键词：
dyskinesia; glutamate; metabotropic glutamate receptors; mGlu(2) receptors; mGlu(3) receptors; mGlu(4) receptors; mGlu(5) receptors; parkinsonism; Parkinson's disease; psychosis; LEVODOPA-INDUCED DYSKINESIA; MECHANISMS; AFQ056;
D O I：
10.2217/nmt-2023-0016
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：203 / 206
页数：4
相关论文
共 50 条
  • [21] The role of metabotropic glutamate receptors 7 in several models of Parkinson's disease
    Greco, B.
    Lopez, S.
    Van der Putten, H.
    Flor, P. J.
    Amalric, M.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S36 - S36
  • [22] Modulation of the basal ganglia by metabotropic glutamate receptors: Potential novel approaches for the treatment of Parkinson's disease
    Jones, CK
    Marino, MJ
    Nong, Y
    Valenti, O
    Kinney, GG
    Poisik, O
    Williams, L
    Smith, Y
    Conn, PJ
    NEUROPHARMACOLOGY, 2005, 49 : 251 - 251
  • [23] Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson's disease
    Lopez, Sebastien
    Turle-Lorenzo, Nathalie
    Acher, Francine
    De Leonibus, Elvira
    Mele, Andrea
    Amalric, Marianne
    JOURNAL OF NEUROSCIENCE, 2007, 27 (25): : 6701 - 6711
  • [24] Metabotropic glutamate receptors: targets for neuroprotective therapies in Parkinson disease
    Masilamoni, Gunasingh J.
    Smith, Yoland
    CURRENT OPINION IN PHARMACOLOGY, 2018, 38 : 72 - 80
  • [25] Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia
    Bita Moghaddam
    Psychopharmacology, 2004, 174 : 39 - 44
  • [26] Targeting metabotropic glutamate receptors in the treatment of primary brain tumors
    Iacovelli, Luisa
    Orlando, Rosamaria
    Rossi, Alessandro
    Spinsanti, Paola
    Melchiorri, Daniela
    Nicoletti, Ferdinando
    CURRENT OPINION IN PHARMACOLOGY, 2018, 38 : 59 - 64
  • [27] Role of metabotropic glutamate receptors in striatal cholinergic transmission: Implications for Parkinson's disease
    Bonsi, P
    Cuomo, D
    Calabresi, P
    Bernardi, G
    MOVEMENT DISORDERS, 2004, 19 : S47 - S47
  • [28] Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia
    Moghaddam, B
    PSYCHOPHARMACOLOGY, 2004, 174 (01) : 39 - 44
  • [29] NMDA-metabotropic glutamate receptors interaction in a rat model of Parkinson's disease
    Breysse, N
    Amalric, M
    BEHAVIOURAL PHARMACOLOGY, 2003, 14 : S75 - S75
  • [30] Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson's disease
    Di Menna, Luisa
    Alborghetti, Marika
    De Bartolo, Maria Ilenia
    Borro, Marina
    Gentile, Giovanna
    Zinni, Manuela
    Bologna, Matteo
    Cutrona, Carolina
    D'Errico, Giovanna
    Imbriglio, Tiziana
    Bucci, Domenico
    Merlo, Sara
    Ginerete, Roxana Paula
    Orlando, Rosamaria
    Carrillo, Federica
    Fortunato, Giorgio
    Cannella, Milena
    Sortino, Maria Angela
    Pansiot, Julien
    Baud, Olivier
    Nicoletti, Ferdinando
    Bruno, Valeria
    Simmaco, Maurizio
    Pontieri, Francesco Ernesto
    Bianchini, Edoardo
    Rinaldi, Domiziana
    de Curtis, Amalia
    De Gaetano, Giovanni
    Iacoviello, Licia
    Esposito, Teresa
    Berardelli, Alfredo
    Battaglia, Giuseppe
    NPJ PARKINSONS DISEASE, 2025, 11 (01)
12345